Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

Molecular Partners Ag (MOLN) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Molecular Partners Ag (MOLN) over the last 3 years, with Q4 2023 value amounting to $2.13.

  • Molecular Partners Ag's Shares Outstanding (Weighted Average) fell 4345.3% to $2.13 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.13, marking a year-over-year decrease of 4345.3%. This contributed to the annual value of $2.13 for FY2023, which is 4345.3% down from last year.
  • Per Molecular Partners Ag's latest filing, its Shares Outstanding (Weighted Average) stood at $2.13 for Q4 2023, which was down 4345.3% from $6.57 recorded in Q3 2023.
  • Molecular Partners Ag's Shares Outstanding (Weighted Average)'s 5-year high stood at $6.57 during Q3 2023, with a 5-year trough of $1.26 in Q4 2020.
  • For the 3-year period, Molecular Partners Ag's Shares Outstanding (Weighted Average) averaged around $4.58, with its median value being $5.13 (2022).
  • Data for Molecular Partners Ag's Shares Outstanding (Weighted Average) shows a peak YoY increase of 5207.75% (in 2023) and a maximum YoY decrease of 4345.3% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows Molecular Partners Ag's Shares Outstanding (Weighted Average) stood at $1.26 in 2020, then surged by 198.81% to $3.77 in 2022, then plummeted by 43.45% to $2.13 in 2023.
  • Its Shares Outstanding (Weighted Average) stands at $2.13 for Q4 2023, versus $6.57 for Q3 2023 and $6.45 for Q2 2023.